| Literature DB >> 24740570 |
Alberto Bartolomé1, Maki Kimura-Koyanagi2, Shun-Ichiro Asahara2, Carlos Guillén3, Hiroyuki Inoue4, Kyoko Teruyama4, Shinobu Shimizu4, Ayumi Kanno2, Ana García-Aguilar3, Masato Koike5, Yasuo Uchiyama5, Manuel Benito3, Tetsuo Noda6, Yoshiaki Kido7.
Abstract
Hyperactivation of the mammalian target of rapamycin complex 1 (mTORC1) in β-cells is usually found as a consequence of increased metabolic load. Although it plays an essential role in β-cell compensatory mechanisms, mTORC1 negatively regulates autophagy. Using a mouse model with β-cell-specific deletion of Tsc2 (βTsc2(-/-)) and, consequently, mTORC1 hyperactivation, we focused on the role that chronic mTORC1 hyperactivation might have on β-cell failure. mTORC1 hyperactivation drove an early increase in β-cell mass that later declined, triggering hyperglycemia. Apoptosis and endoplasmic reticulum stress markers were found in islets of older βTsc2(-/-) mice as well as accumulation of p62/SQSTM1 and an impaired autophagic response. Mitochondrial mass was increased in β-cells of βTsc2(-/-) mice, but mitophagy was also impaired under these circumstances. We provide evidence of β-cell autophagy impairment as a link between mTORC1 hyperactivation and mitochondrial dysfunction that probably contributes to β-cell failure.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24740570 DOI: 10.2337/db13-0970
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461